Similar content being viewed by others
This article is cited by
-
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
Nature Reviews Clinical Oncology (2024)
-
TTN-AS1 delivered by gastric cancer cell–derived exosome induces gastric cancer progression through in vivo and in vitro studies
Cell Biology and Toxicology (2023)
-
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract
Journal of Cancer Research and Clinical Oncology (2023)
-
Therapeutisch relevante prädiktive Biomarker beim Adenokarzinom des Ösophagus
Die Onkologie (2023)
-
Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis
BMC Cancer (2022)